Headline
The latest stories from AHA Today.
Pfizer announced its formal request that the Food and Drug Administration authorize the emergency use of its PAXLOVID (PF-07321332; ritonavir) oral antiviral for combatting SARS-CoV-2.
The AHA urged the Department of Health and Human Services’ Office for Civil Rights to quickly initiate rulemaking for a legislative provision (H.R. 7898) enacted by Congress this year to recognize certain recommended security practices when making determinations related to Health Insurance…
The AHA urged the Senate Finance Committee to address the nation’s myriad behavioral health needs by: strengthening the workforce; reforming discriminatory Medicare and Medicaid laws; increasing integration, coordination and access to care; ensuring parity; expanding telehealth; and improving care…
Sens. Mark Kelly, D-Ariz., and Bill Cassidy, R-La., and Reps. Doris Matsui, D-Calif., and David McKinley, R- W.Va., urged the White House to enlist federal agencies to investigate price gouging by nurse staffing agencies.
Community investments help foster the social and physical environments that support communities’ long-term health.
A recent opinion piece in The Hill promoting physician-owned hospitals gives a misleading and incomplete account of these facilities and the reasons for current statutory restrictions on their growth, writes Ashley Thompson, senior vice president for public policy analysis and development at the…
Ellume has expanded its recall of rapid at-home COVID-19 antigen tests to about 2 million tests, the Food and Drug Administration said in an update this week.
The Centers for Disease Control and Prevention’s National Institute for Occupational Safety and Health will host a virtual panel discussion Nov. 18 at 2:30 p.m. ET on protecting the mental health of the nation’s health care workforce.
AHA President and CEO Rick Pollack talks with Epstein Becker Green podcast host Edward Kennedy Jr. about how hospitals are working with the Administration and Congress to shape policy around critical issues such as surprise billing, coverage expansion, value-based care and telehealth.
President Biden nominated former Food and Drug Administration Commissioner Robert Califf to resume his leading role at the agency. Califf, a cardiologist, helmed FDA for nearly a year during the Obama administration.